WindRose Health Investors Recapitalizes Terrapin Pharmacy

WindRose Health Investors Recapitalizes Traditions Behavioral Health

November 14, 2018

Healthcare Services

Funds managed by WindRose Health Investors completed a recapitalization of Traditions Behavioral Health (TBH), a West Coast provider of permanent outsourced physician psychiatric services. WindRose partnered with TBH's executive team (founder and CEO Gary A. Hayes remains in place) to provide growth capital to expand into new U.S. markets, broaden services and increase its network of psychiatrists.

WindRose Health Investors Acquires Ganse Apothecary and Integrates It with Terrapin Pharmacy

July 14, 2022

Healthcare Services

WindRose Health Investors completed the acquisition of Ganse Apothecary and merged it with Terrapin Pharmacy, an existing WindRose portfolio company, to create a behavioral health-focused pharmacy platform in the Mid-Atlantic. The combined business expands footprint and capabilities across Pennsylvania and surrounding states, serving approximately 7,500 patients across four states; terms were not disclosed.

WindRose Health Investors Recapitalizes RevHealth

July 27, 2022

Healthcare Services

WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.

WindRose Health Investors Recapitalizes Healthmap Solutions

May 21, 2019

Healthcare Services

WindRose Health Investors completed an $85 million equity recapitalization of Healthmap Solutions to provide growth capital and support the company's expansion into new markets. Healthmap, a specialty population health management firm focused on kidney disease, will continue to be led by CEO Joe Vattamattam and COO & Founder Andrew Wall.

WindRose Health Investors Recapitalizes Lykan Bioscience Holdings

June 4, 2019

Biotechnology

WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.

WindRose Health Investors Recapitalizes Bluestone Physician Services

April 14, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.